These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29222866)

  • 61. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
    Fidler S; Swaminathan R; Lim W; Ferrari P; Witt C; Christiansen FT; D'Orsogna LJ; Irish AB
    Transpl Immunol; 2013 Dec; 29(1-4):22-7. PubMed ID: 24090807
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Maternal grafts protect daughter recipients from acute cellular rejection after pediatric living donor liver transplantation for biliary atresia.
    Sanada Y; Kawano Y; Miki A; Aida J; Nakamura K; Shimomura N; Ishikawa N; Arai T; Hirata Y; Yamada N; Okada N; Wakiya T; Ihara Y; Urahashi T; Yasuda Y; Takubo K; Mizuta K
    Transpl Int; 2014 Apr; 27(4):383-90. PubMed ID: 24472036
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation.
    Kfoury AG; Renlund DG; Snow GL; Stehlik J; Folsom JW; Fisher PW; Reid BB; Clayson SE; Gilbert EM; Everitt MD; Bader FM; Singhal AK; Hammond ME
    J Heart Lung Transplant; 2009 Jan; 28(1):51-7. PubMed ID: 19134531
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of HLA-G transcripts in graft biopsy samples of renal transplant recipients.
    Žilinská Z; Bandžuchová H; Chrastina M; Trebatický B; Breza J; Handzušová M; Kuba D; Tirpáková J; Pavlechová M; Dedinská I; Rychlý B; Poláková K
    Transpl Immunol; 2015 Nov; 33(3):159-65. PubMed ID: 26455418
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The use of Doppler tissue imaging to predict cellular and antibody-mediated rejection in pediatric heart transplant recipients.
    Behera SK; Trang J; Feeley BT; Levi DS; Alejos JC; Drant S
    Pediatr Transplant; 2008 Mar; 12(2):207-14. PubMed ID: 18307670
    [TBL] [Abstract][Full Text] [Related]  

  • 67. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.
    Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ
    Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Early screening for antibody-mediated rejection in heart transplant recipients.
    Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
    J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
    Ixtlapale-Carmona X; Arvizu A; De-Santiago A; González-Tableros N; López M; Castelán N; Marino LA; Uribe-Uribe NO; Contreras AG; Vilatobá M; Morales-Buenrostro LE; Alberú J
    Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients.
    Clemmensen TS; Eiskjær H; Løgstrup BB; Ilkjær LB; Poulsen SH
    J Heart Lung Transplant; 2017 May; 36(5):567-576. PubMed ID: 28089194
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bortezomib use in a pediatric cardiac transplant center.
    Zinn MD; L'Ecuyer TJ; Fagoaga OR; Aggarwal S
    Pediatr Transplant; 2014 Aug; 18(5):469-76. PubMed ID: 24931171
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.
    Li F; Wei J; Valenzuela NM; Lai C; Zhang Q; Gjertson D; Fishbein MC; Kobashigawa JA; Deng M; Reed EF
    J Heart Lung Transplant; 2015 Apr; 34(4):580-587. PubMed ID: 25511749
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Validation of a Simple Score to Determine Risk of Early Rejection After Pediatric Heart Transplantation.
    Butts RJ; Savage AJ; Atz AM; Heal EM; Burnette AL; Kavarana MM; Bradley SM; Chowdhury SM
    JACC Heart Fail; 2015 Sep; 3(9):670-6. PubMed ID: 26362445
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of ischemic time on early rejection after pediatric heart transplant.
    Magdo HS; Friedland-Little JM; Yu S; Gajarski RJ; Schumacher KR
    Pediatr Transplant; 2017 Dec; 21(8):. PubMed ID: 28913983
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients.
    Mincham CM; Wong G; Teixeira-Pinto A; Kennedy S; Alexander S; Larkins N; Lim WH
    Transplantation; 2017 Sep; 101(9):2146-2151. PubMed ID: 28832451
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience.
    Grupper A; Nestorovic EM; Daly RC; Milic NM; Joyce LD; Stulak JM; Joyce DL; Edwards BS; Pereira NL; Kushwaha SS
    Transplant Direct; 2016 Oct; 2(10):e106. PubMed ID: 27795988
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?
    Revelo MP; Stehlik J; Miller D; Snow GL; Everitt MD; Budge D; Bader FM; Alharethi RA; Gilbert EM; Reid BB; Selzman CH; Hammond ME; Kfoury AG
    J Heart Lung Transplant; 2011 Feb; 30(2):144-50. PubMed ID: 20855221
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Has late rejection decreased in pediatric heart transplantation in the current era? A multi-institutional study.
    Ameduri RK; Zheng J; Schechtman KB; Hoffman TM; Gajarski RJ; Chinnock R; Naftel DC; Kirklin JK; Dipchand AI; Canter CE
    J Heart Lung Transplant; 2012 Sep; 31(9):980-6. PubMed ID: 22884385
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of flow PRA on outcome in pediatric heart recipients in modern era: An analysis of the Pediatric Heart Transplant Study database.
    Das BB; Pruitt E; Molina K; Ravekes W; Auerbach S; Savage A; Knox L; Kirklin JK; Naftel DC; Hsu D;
    Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29144053
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biomarkers of heart transplant rejection: the good, the bad, and the ugly!
    Labarrere CA; Jaeger BR
    Transl Res; 2012 Apr; 159(4):238-51. PubMed ID: 22424428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.